sec filing
NASDAQ · AVXL
Anavex Life Sciences Corp.
Healthcare · Biotechnology
$1.19
Down-$0.11 (-8.46%)
Updated Nov 2, 2026, 5:19 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 367.21M
- P/E ratio
- -7.28
- Dividend yield
- 0.00%
- 52-week range
- $1.14 – $8.35
- Volume
- 1.2M
- Avg. volume
- 2.3M
Price performance · AVXL
AVXL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
AVXL closed at $1.19 after 20 trading sessions, down 27.66% for the selected period.
- Last close
- $1.19
- Period change
- -27.66%
- Period low
- $1.19
- Period high
- $1.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.30 | $1.30 | $1.18 | $1.19 | 1.2M |
| Oct 29, 2026 | $1.31 | $1.32 | $1.27 | $1.30 | 900.16K |
| Oct 28, 2026 | $1.30 | $1.305 | $1.245 | $1.30 | 1.02M |
| Oct 27, 2026 | $1.28 | $1.315 | $1.25 | $1.31 | 1.35M |
| Oct 26, 2026 | $1.30 | $1.31 | $1.255 | $1.28 | 912.38K |
| Oct 23, 2026 | $1.34 | $1.3488 | $1.29 | $1.33 | 627.22K |
| Oct 22, 2026 | $1.33 | $1.405 | $1.33 | $1.36 | 1.02M |
| Oct 21, 2026 | $1.40 | $1.40 | $1.31 | $1.36 | 1.06M |
| Oct 20, 2026 | $1.25 | $1.40 | $1.225 | $1.36 | 1.67M |
| Oct 19, 2026 | $1.30 | $1.31 | $1.14 | $1.25 | 1.87M |
| Oct 16, 2026 | $1.47 | $1.47 | $1.30 | $1.31 | 1.47M |
| Oct 15, 2026 | $1.50 | $1.54 | $1.47 | $1.48 | 1.77M |
| Oct 14, 2026 | $1.45 | $1.55 | $1.45 | $1.49 | 1.23M |
| Oct 13, 2026 | $1.53 | $1.53 | $1.475 | $1.48 | 1.19M |
| Oct 12, 2026 | $1.47 | $1.54 | $1.445 | $1.51 | 1.19M |
| Oct 9, 2026 | $1.54 | $1.54 | $1.44 | $1.49 | 1.29M |
| Oct 8, 2026 | $1.53 | $1.58 | $1.50 | $1.54 | 1.47M |
| Oct 7, 2026 | $1.57 | $1.61 | $1.515 | $1.53 | 1.34M |
| Oct 6, 2026 | $1.66 | $1.71 | $1.56 | $1.60 | 1.44M |
| Oct 5, 2026 | $1.79 | $1.815 | $1.63 | $1.645 | 2.03M |
Latest AVXL news
The latest Smart Investors Daily articles mentioning AVXL.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…